SL Science Holding Ltd (SLBT) Stock Analysis & Investment Frameworks
SL Science Holding Ltd (SLBT) stock analysis on Invetso. Review SL Science Holding Ltd’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
SL Science Holding Ltd Company Overview
- Exchange: NASDAQ Global Market
- Sector: Healthcare
- Industry: Biotechnology
- Country: US
SL Science Holding Ltd Key Financial Metrics
- Market Cap: $813.10M
- Revenue: $2.20M
- ROE: -95.36%
- ROIC: -153.66%
- Dividend Yield: N/A
About SL Science Holding Ltd
SL Science Holding Limited manufactures cosmetic skin care and scalp care products. The company’s products include SL bio’s milk-derived exosome essence, SL bio’s tangerine-derived extract, and the MilkExo concentrate series. It also offers research services in armed T-cells, gamma delta T- cells, citrus reticulata (tangerine) extract, and milk-derived exosomes. SL Science Holding Limited was formerly known as SL BIO Co., Ltd. and changed its name to SL Science Holding Limited in June 2026. The company is based in Taipei, Taiwan.